Generic versions of Ozempic may reduce costs in Canada, but experts say approval is unlikely before late spring or summer 2026. Health Canada is reviewing multiple submissions, with prices potentially dropping to 35% of brand-name costs. Affordability remains the biggest barrier for patients needing semaglutide treatment.
We'll keep you updated on all new application updates and features!